MBNL1
Muscleblind-like protein 1
Also known as: EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL, MBNL1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NR56
- Gene
- MBNL1
- Ensembl
- ENSG00000152601
- Chromosome
- 3
- Canonical length
- 388 aa
- Protein class
- Disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a member of the muscleblind protein family which was initially described in Drosophila melanogaster. The encoded protein is a C3H-type zinc finger protein that modulates alternative splicing of pre-mRNAs. Muscleblind proteins bind specifically to expanded dsCUG RNA but not to normal size CUG repeats and may thereby play a role in the pathophysiology of myotonic dystrophy. Mice lacking this gene exhibited muscle abnormalities and cataracts. Several alternatively spliced transcript variants have been described but the full-length natures of only some have been determined. The different isoforms are thought to have different binding specificities and/or splicing activities. [provided by RefSeq, Sep 2015]
Canonical amino-acid sequenceUniProt
388 residues, UniProt reviewed canonical sequence.
>Q9NR56|MBNL1
1 MAVSVTPIRD TKWLTLEVCR EFQRGTCSRP DTECKFAHPS KSCQVENGRV IACFDSLKGR
61 CSRENCKYLH PPPHLKTQLE INGRNNLIQQ KNMAMLAQQM QLANAMMPGA PLQPVPMFSV
121 APSLATNASA AAFNPYLGPV SPSLVPAEIL PTAPMLVTGN PGVPVPAAAA AAAQKLMRTD
181 RLEVCREYQR GNCNRGENDC RFAHPADSTM IDTNDNTVTV CMDYIKGRCS REKCKYFHPP
241 AHLQAKIKAA QYQVNQAAAA QAAATAAAMT QSAVKSLKRP LEATFDLGIP QAVLPPLPKR
301 PALEKTNGAT AVFNTGIFQY QQALANMQLQ QHTAFLPPVP MVHGATPATV SAATTSATSV
361 PFAATATANQ IPIISAEHLT SHKYVTQMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MBNL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 177 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 177 nTPM
- blood vessel: 142 nTPM
- lymph node: 127 nTPM
- tongue: 123 nTPM
- tonsil: 123 nTPM
- smooth muscle: 107 nTPM
Single-cell type
- neutrophils: 5,223 nCPM
- myonuclei: 4,765 nCPM
- neutrophil progenitors: 3,513 nCPM
- monocyte progenitors: 3,082 nCPM
- hematopoietic stem cells: 2,628 nCPM
- thymic myoid cells: 2,413 nCPM
Immune cell
- total PBMC: 101 nTPM
- basophil: 91 nTPM
- eosinophil: 86 nTPM
- MAIT T-cell: 80 nTPM
- neutrophil: 77 nTPM
- NK-cell: 76 nTPM
Brain region
- white matter: 107 nTPM
- pons: 99 nTPM
- medulla oblongata: 97 nTPM
- thalamus: 96 nTPM
- spinal cord: 96 nTPM
- basal ganglia: 93 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MBNL1.
Disease | AllUniProt
Conditions MBNL1 is implicated in, by any mechanism.
- Dystrophia myotonica 1 (DM1) MIM:160900
- Corneal dystrophy, Fuchs endothelial, 3 (FECD3) MIM:613267
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.71
- gnomAD missense Z
- 2.7
- DepMap mean gene effect
- -0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- embryonic limb morphogenesis
- in utero embryonic development
- mRNA processing
- myoblast differentiation
- nervous system development
- regulation of RNA splicing
- RNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MBNL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MBNL1 as an antibody target. Whether an autoantibody or antibody against MBNL1 could matter depends on whether native MBNL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MBNL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MBNL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...